Early Rheumatoid Arthritis: Biomarker Study for Abatacept

We are investigating if certain biomarkers can predict how well patients with early rheumatoid arthritis respond to abatacept treatment. This may help tailor therapies to individual needs.

3-6 months≤5 visitsMonitoring phase (IV)Cost ReimbursementPartially RemoteInvestigational MedicinesInjectionRheumatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Orencia
Orencia is a medicine used to treat rheumatoid arthritis and related conditions by helping reduce joint inflammation and pain.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Abatacept
Abatacept is a substance that reduces immune system overactivity to treat autoimmune conditions such as rheumatoid arthritis.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Abatacept

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Cliniques Universitaires Saint-Luc
Rheumatology
Sint-Stevens-Woluwe, Belgium
Azienda Ospedaliero-Universitaria Di Cagliari
Rheumatology
Monserrato, Italy
Azienda Ospedaliero-Universitaria Maggiore Della Carita
Rheumatology
Novara, Italy
Sponsor: Queen Mary University Of London
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.